Allergy Therapeutics presents findings at EAACI | Company Announcement
Investegate announcements from Allergy Therapeutics presents findings at EAACI
Stay updated with breaking news from Emma Earl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Allergy Therapeutics presents findings at EAACI
Investegate announcements from Grant of Options and PDMR Dealing
Investegate announcements from Positive headline results for AT278 clinical trial
Investegate announcements from Publication of Full Year Financial Results delayed
Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that Monument Therapeutics Limited (“Monument”) a p...